First AD

Second AD

Safety Considerations for PV Therapy

Video content above is prompted by the following:

What are your thoughts on the safety profiles of these therapies for PV?

What safety considerations do you weigh when determining which patients are best suited for these therapies?

Video Series

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

ASH 2024: Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care  

Peer Exchange

Panelists discuss the safety profiles of therapies for polycythemia vera (PV) and the safety considerations they take into account when determining which patients are best suited for these treatments.